Enhanced osteogenic differentiation of alendronate-conjugated nanodiamonds for potential osteoporosis treatment
Abstract Background Alendronate (Alen) is promising material used for bone-targeted drug delivery due to its high bone affinity and therapeutic effects on bone diseases. In addition, Alen can enhance the osteogenic differentiation of osteoblastic cell. Recently, nanodiamonds (NDs) with hardness, non...
Main Authors: | Guk Young Ahn, Sung-Eun Kim, Tae Hoon Yun, Inseong Choi, Daewon Park, Sung-Wook Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
American Association for the Advancement of Science (AAAS)
2021-09-01
|
Series: | Biomaterials Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40824-021-00231-9 |
Similar Items
-
Use of alendronate in the therapy of osteoporosis
by: O. B. Ershova
Published: (2020-01-01) -
The Effect of Alendronate in Male Osteoporosis
by: Özlem El, et al.
Published: (2004-12-01) -
Icariin-Functionalized Nanodiamonds to Enhance Osteogenic Capacity In Vitro
by: Somang Choi, et al.
Published: (2020-10-01) -
Nanodiamond /
by: Williams, Oliver, editor
Published: (2014) -
The Effect of Once-Weekly 70 Mg Alendronate Versus Once-Daily 10 Mg Alendronate in the Treatment of Postmenopausal Osteoporosis
by: İlker Çorapçı, et al.
Published: (2004-03-01)